Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-030224

Chief Financial Officer sold 3,900 shares at $29.88 ($116,550)

  • Chief Financial Officer acquired 3,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Viret Jean-Frederic · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-26 Exercise or conversion : show line 1 in the form +3,900 $13.50 $52,650 6,225 D
2016-09-26 Sale : show line 2 in the form −3,900 $29.88 $116,550 2,325 D
Open-market sales · 3,900 sh · avg $29.88 · $116,550

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-09-26 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −3,900 128,748 D
Loading xslF345X03/doc4.xml…